rs2700
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001042618.2(PARP2):c.*9A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.281 in 1,607,518 control chromosomes in the GnomAD database, including 65,395 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.23 ( 4699 hom., cov: 32)
Exomes 𝑓: 0.29 ( 60696 hom. )
Consequence
PARP2
NM_001042618.2 3_prime_UTR
NM_001042618.2 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.155
Genes affected
PARP2 (HGNC:272): (poly(ADP-ribose) polymerase 2) This gene encodes poly(ADP-ribosyl)transferase-like 2 protein, which contains a catalytic domain and is capable of catalyzing a poly(ADP-ribosyl)ation reaction. This protein has a catalytic domain which is homologous to that of poly (ADP-ribosyl) transferase, but lacks an N-terminal DNA binding domain which activates the C-terminal catalytic domain of poly (ADP-ribosyl) transferase. The basic residues within the N-terminal region of this protein may bear potential DNA-binding properties, and may be involved in the nuclear and/or nucleolar targeting of the protein. Two alternatively spliced transcript variants encoding distinct isoforms have been found. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.344 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PARP2 | ENST00000429687.8 | c.*9A>C | 3_prime_UTR_variant | Exon 16 of 16 | 1 | NM_001042618.2 | ENSP00000392972.3 | |||
PARP2 | ENST00000250416.9 | c.*9A>C | 3_prime_UTR_variant | Exon 16 of 16 | 1 | ENSP00000250416.5 | ||||
PARP2 | ENST00000527915.5 | c.*282A>C | 3_prime_UTR_variant | Exon 15 of 15 | 2 | ENSP00000432283.1 | ||||
PARP2 | ENST00000539930.1 | c.*133A>C | downstream_gene_variant | 3 | ENSP00000445524.1 |
Frequencies
GnomAD3 genomes AF: 0.231 AC: 35141AN: 152060Hom.: 4703 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
35141
AN:
152060
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.280 AC: 68499AN: 244884 AF XY: 0.285 show subpopulations
GnomAD2 exomes
AF:
AC:
68499
AN:
244884
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.286 AC: 416019AN: 1455340Hom.: 60696 Cov.: 31 AF XY: 0.288 AC XY: 208675AN XY: 723900 show subpopulations
GnomAD4 exome
AF:
AC:
416019
AN:
1455340
Hom.:
Cov.:
31
AF XY:
AC XY:
208675
AN XY:
723900
Gnomad4 AFR exome
AF:
AC:
3039
AN:
33202
Gnomad4 AMR exome
AF:
AC:
11007
AN:
43488
Gnomad4 ASJ exome
AF:
AC:
6584
AN:
26056
Gnomad4 EAS exome
AF:
AC:
10752
AN:
39670
Gnomad4 SAS exome
AF:
AC:
29320
AN:
85138
Gnomad4 FIN exome
AF:
AC:
16250
AN:
53396
Gnomad4 NFE exome
AF:
AC:
321201
AN:
1108434
Gnomad4 Remaining exome
AF:
AC:
16391
AN:
60202
Heterozygous variant carriers
0
14723
29446
44169
58892
73615
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
10592
21184
31776
42368
52960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.231 AC: 35140AN: 152178Hom.: 4699 Cov.: 32 AF XY: 0.231 AC XY: 17217AN XY: 74382 show subpopulations
GnomAD4 genome
AF:
AC:
35140
AN:
152178
Hom.:
Cov.:
32
AF XY:
AC XY:
17217
AN XY:
74382
Gnomad4 AFR
AF:
AC:
0.0938673
AN:
0.0938673
Gnomad4 AMR
AF:
AC:
0.225739
AN:
0.225739
Gnomad4 ASJ
AF:
AC:
0.261095
AN:
0.261095
Gnomad4 EAS
AF:
AC:
0.277606
AN:
0.277606
Gnomad4 SAS
AF:
AC:
0.357735
AN:
0.357735
Gnomad4 FIN
AF:
AC:
0.305545
AN:
0.305545
Gnomad4 NFE
AF:
AC:
0.290506
AN:
0.290506
Gnomad4 OTH
AF:
AC:
0.244087
AN:
0.244087
Heterozygous variant carriers
0
1381
2761
4142
5522
6903
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
392
784
1176
1568
1960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at